Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Measurement and Interpretation of the Ankle-Brachial Index
2012
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Hyperbaric oxygen therapy and the diabetic foot
1997
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Homocysteine and vascular disease
1999 Standout
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Escore para rastrear idosos (> 75 anos) de alto risco para doença arterial periférica
2007
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Chronic Venous Disease
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Erectile Dysfunction
2000 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials
2008
Antithrombotic Therapy for VTE Disease
2016 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Exercise Standards for Testing and Training
2013 Standout
Preventing and treating foot complications associated with diabetes mellitus
2015
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
Pharmacotherapy for critical limb ischaemia
2000
Describing reporting guidelines for health research: a systematic review
2011
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds
2020 Standout
The Effect of Novel Cardiovascular Risk Factors on the Ethnic-Specific Odds for Peripheral Arterial Disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
2006
Platelets in inflammation and atherogenesis
2005 Standout
Oral Beraprost Sodium, a Prostaglandin I 2 Analogue, for Intermittent Claudication
2000
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
2006
Blood Lipid and Lipoprotein Adaptations to Exercise
2001
The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene
2001
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Alcohol Consumption and Risk of Peripheral Arterial Disease : The Rotterdam Study
2002
Leukocyte activation in patients with venous insufficiency
1999
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
2004
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
The post-thrombotic syndrome: current knowledge, controversies, and directions for future research
2002
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Treatment of Intermittent Claudication With Physical Training, Smoking Cessation, Pentoxifylline, or Nafronyl
1999
Pharmacokinetics and Bioavailability of Herbal Medicinal Products
2002
Trans-Atlantic Conference on Clinical Trial Guidelines in PAOD (Peripheral Arterial Occlusive Disease) Clinical Trial Methodology
1999
A randomized clinical trial of endovenous laser ablation versus conventional surgery for small saphenous varicose veins
2015 StandoutNobel
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Homocysteine and Peripheral Arterial Disease: Systematic Review and Meta-analysis
2009
Herbal Medicine for the Treatment of Cardiovascular Disease
1998
Aerobic Exercise and Lipids and Lipoproteins in Women: A Meta-Analysis of Randomized Controlled Trials
2004
Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease
2016 StandoutNobel
Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar®
2000
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Exercise for overweight or obesity
2006
The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers
1991
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Copper Active Sites in Biology
2014 Standout
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Herbal medicine for the treatment of cardiovascular disease: clinical considerations.
1998
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
1996
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
1997
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
1997
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial)
2006
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
1985 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Treatment of Lower Limb Ischaemia Due to Atherosclerosis in Diabetic and Nondiabetic Patients with Iloprost, a Stable Analogue of Prostacyclin
1991
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Prostanoids for critical limb ischaemia
2018
Systematic review of compression following treatment for varicose veins
2015 StandoutNobel
Epidemiology of Peripheral Artery Disease
2015 Standout
Differential Effects of Exercise on Serum Lipid and Lipoprotein Levels Seen With Changes in Body Weight
1985
Ischemic Cell Death in Brain Neurons
1999 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Daily variations of plasma glucose and insulin in physically-trained and sedentary subjects
1983
Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets
1997
Impact of a 4-Week Treatment with Prostaglandin E1 on Health-Related Quality of Life of Patients with Intermittent Claudication
2000
Homocysteine and Cardiovascular Disease
1998 Standout
Exercise for intermittent claudication
2017
A Review of the Potential Local Mechanisms by Which Exercise Improves Functional Outcomes in Intermittent Claudication
2015
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Vascular Calcification
2006 Standout
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
2013
Prospective study of 713 below–knee amputations for ischaemia and the effect of a prostacyclin analogue on healing
1994
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.
1992
Works of C. Diehm being referenced
Prostaglandin E[1] : new aspects on pharmacology, metabolism, and clinical efficacy
1991
Critical limb ischaemia: a case against Consensus II.
1995
Prävalenz der Hyperhomocysteinämie bei der Thrombangiitis obliterans: Spielt Homocystein pathogenetisch eine Rolle?
2008
Treadmill testing for evaluation of claudication: Comparison of constant-load and graded-exercise tests
1997
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross‐sectional study of 6880 primary care patients
2003
A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries
2007
Iloprost, ein stabiles Prostacyclinderivat, bei arterieller Verschlußkrankheit im Stadium IV: Eine placebo-kontrollierte Multizenterstudie
2008
Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency
1996
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occulsive disease
1991
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial
1997
Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost.
1992
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative].
1990
Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
1987
[Acute effect of alcohol on peripheral circulation in normal persons and patients with peripheral occlusive diseases].
1983
Oscillometric measurement of ankle-brachial index in patients with suspected peripheral disease: comparison with Doppler method
2009
Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
1989
[Effect of a 2-year ambulatory vascular sports program on walking distance in claudication patients--a controlled study].
1991
Medical edema protection--clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study.
1992
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
1989
Effect of prolonged exercise on serum lipids and lipoproteins
1983
[Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
1992
Prostaglandin E1 bei arterieller Verschlußkrankheit im Stadium III und IV: Ergebnisse einer multizentrischen Studie
2008
Activation and decreased deformability of neutrophils after intermittent claudication.
1990
[Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
1991
Training-induced changes in serum lipids, fat tolerance, and adipose tissue metabolism in patients with hypertriglyceridemia
1985
Plasma C-peptide and insulin in trained and untrained subjects
1981
Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease.
1991
Prostaglandin E1 in chronic arterial disease: a multicenter study.
1987
Prostaglandin E1 in chronic arterial disease--a multicenter study.
1987